| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 3.67M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HOWL returned -33.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +37.9% |
| 1 year | -33.8% |
| 5 years | -95.1% |
| All-time high | $17.80 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HOWL would be worth today ›No. Werewolf Therapeutics, Inc. has not paid a dividend in the past 12 months.
Werewolf Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol HOWL.
Werewolf Therapeutics, Inc. is part of the Healthcare sector.
Werewolf Therapeutics, Inc. has a market cap of 42.45M USD, based on the latest quote.
Werewolf Therapeutics, Inc. is expected to report earnings around Oct 30, 2026. That date is an estimate and has not been confirmed by the company.
